Solitaire FR device for treatment of dural sinus thrombosis.
Publication/Presentation Date
1-1-2014
Abstract
Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.
Volume
6
Issue
1
First Page
2
Last Page
2
ISSN
1759-8486
Published In/Presented At
Pukenas, B. A., Kumar, M., Stiefel, M., Smith, M., & Hurst, R. (2014). Solitaire FR device for treatment of dural sinus thrombosis. Journal of neurointerventional surgery, 6(1), e2. https://doi.org/10.1136/neurintsurg-2012-010543.rep
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23299102
Department(s)
Administration and Leadership
Document Type
Article